CJC-1295 with DAC

Long-acting growth-hormone research · From $35

Overview

A bioconjugate-enabled analogue of GHRH(1-29) in which the tetrasubstituted 29-residue backbone is extended by a C-terminal lysine bearing a maleimidopropionyl group, the so-called drug affinity complex (DAC). The maleimide moiety reacts selectively with the free cysteine-34 thiol of serum albumin, and this covalent albumin conjugation is the mechanistic basis studied in preclinical models for its markedly extended circulating residence relative to unconjugated GHRH fragments. It is investigated in vitro and in rodent models as a GHRH receptor agonist and as a model system for albumin-binding peptide conjugation chemistry.

Purity
≥ 99%
Form
Lyophilized powder
Class
30-residue GHRH(1-29) analogue bearing a C-terminal Lys(N-epsilon-3-maleimidopropionyl) drug affinity complex (DAC)
Storage
−20 °C, desiccated, dark

Also known as CJC-1295 DAC, DAC:GRF, Drug Affinity Complex GRF.

1

$35

$17.50 per mg